Pembro With Radiation With or Without Olaparib

Abroad (travel likely)RecruitingPHASE2

Conditions

Prostate Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Kentucky, Lexington, Kentucky, United States
Contact: Study coordinator (Bryan Courtney, RN,CCRC) · bryancourtney@uky.edu · 859-257-5207
Contact: Study coordinator (Zin Myint, MD) · zin.myint@uky.edu · 859-323-3964
Huntsman Cancer Institute, Salt Lake City, Utah, United States

Study leads

Zin W Myint, MD
Principal Investigator
University of Kentucky

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC

PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy

Abroad (travel likely)RecruitingPHASE1, PHASE2

Los Angeles, United States · El Paso, United States

A Clinical Study of [68Ga]Ga-ELI421 Injection PET Imaging in Patients With Prostate Cancer

Prostate Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Wuhan, China

Prospective Clinical Trial of 177Lu-P17-088 in the Treatment of Metastatic Castration-Resistant Prostate Cancer

Prostate Cancer

Abroad (travel likely)RecruitingPHASE2

Fuzhou, China

A Clinical Study of SHR-4394 in Combination With Anti-tumor Therapy in Prostate Cancer

Prostate Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Chengdu, China · Tianjin, China